Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: A Phase l/ll Open-Label, Dose Escalation, Safety and Activity Study of the Antibody-Drug Conjugate CDX-014 in Advanced or Metastatic Renal Cell Carcinoma (RCC)
Brief Summary: This is a study to determine the safety of CDX-014 and effectiveness (how well the drug works).